Cyclica is a biotechnology company that aims to improve drug discovery pipelines by identifying sources of drug failure, such as adverse effects, contraindications, or lack of efficacy, before they result in costly failed clinical trials.
Company (Alive / Active)
18 King Street East
Toronto, M5V 1C4
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)